BioTelemetry, Inc. (BEAT): Price and Financial Metrics
BEAT Price/Volume Stats
| Current price | $2.05 | 52-week high | $6.74 |
| Prev. close | $2.15 | 52-week low | $1.82 |
| Day low | $1.99 | Volume | 18,842 |
| Day high | $2.16 | Avg. volume | 209,419 |
| 50-day MA | $2.39 | Dividend yield | N/A |
| 200-day MA | $2.91 | Market Cap | 53.94M |
BEAT Stock Price Chart Interactive Chart >
BioTelemetry, Inc. (BEAT) Company Bio
BioTelemetry Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. It operates in three segments: Patient Services, Product, and Research Services. The company is based in Malvern, Pennsylvania.
Latest BEAT News From Around the Web
Below are the latest news stories about HEARTBEAM INC that investors may wish to consider to help them evaluate BEAT as an investment opportunity.
Implicity Expands Senior Leadership Team with New U.S. Chief Commercial OfficerImplicity, a leader in remote patient monitoring (RPM) and cardiac data management solutions, announced that Jon Hunt, PhD., has joined the company as its new Chief Commercial Officer (CCO), North America. In this role, Hunt will focus on business and sales strategies for the U.S. market to maximize growth, scale operations, and support technological innovations that help meet the growing demand for remote cardiac monitoring. |
HeartBeam Appoints Richa Gujarati and Pooja Chatterjee to Senior Management TeamSANTA CLARA, Calif., September 26, 2023--HeartBeam Appoints Richa Gujarati and Pooja Chatterjee to Senior Management Team |
Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceJUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8th Annual Dawson James Small Cap Growth Conference on October 12, 2023, at the Wyndham Grand Hotel in Jupiter, FL. Dawson James’ flagship Small Cap Growth Conference brings together senior leadership from over 30 of the most innovative companies at the forefront of healthcare, technology and consu |
Q2 2023 Heartbeam Inc Earnings CallQ2 2023 Heartbeam Inc Earnings Call |
HeartBeam Reports Second Quarter 2023 Financial ResultsSANTA CLARA, Calif., August 10, 2023--HeartBeam Reports Second Quarter 2023 Financial Results |
BEAT Price Returns
| 1-mo | -8.07% |
| 3-mo | N/A |
| 6-mo | -9.69% |
| 1-year | -47.44% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -57.99% |
| 2022 | 58.44% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Continue Researching BEAT
Want to do more research on Biotelemetry Inc's stock and its price? Try the links below:Biotelemetry Inc (BEAT) Stock Price | Nasdaq
Biotelemetry Inc (BEAT) Stock Quote, History and News - Yahoo Finance
Biotelemetry Inc (BEAT) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...